Evidence map›Paper›PMID 33663440›Full record

ArticleBMC psychiatry2021

A surrogate measure for patient reported symptom remission in administrative data.

Farrokh Alemi, Mai Aljuaid, Naren Durbha, Melanie Yousefi, Hua Min, Louisa G Sylvia, Andrew A Nierenberg

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Farrokh AlemiDept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA. falemi@gmu.edu.
Mai AljuaidDept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA.
Naren DurbhaDept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA.
Melanie YousefiSchool of Nursing, College of Health and Human Services, George Mason University, Fairfax, USA.
Hua MinDept. of Health Administration and Policy, College of Health and Human Services, George Mason University, Fairfax, USA.
Louisa G SylviaDauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Andrew A NierenbergDauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
George Mason University · USMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn real-world pragmatic administrative databases, patient reported remission is often missing.

objectiveWe evaluate if, in administrative data, five features of antidepressant use patterns can replace patient-reported symptom remission.

methodWe re-examined data from Sequence Treatment Alternatives to Relieve Depression (STAR*D) study. Remission was measured using 50% reduction in Hamilton index. Pattern of antidepressant use was examined through five variables: (a) number of prior ineffective antidepressants, (b) duration of taking current antidepressant, (c) receiving therapeutic dose of the medication, and (d) switching to another medication, or (e) augmenting with another antidepressant. The likelihood ratio (LR) associated with each of these predictors was assessed in 90% of data (3329 cases) and evaluated in 10% of data (350 cases) set-aside for evaluation. The accuracy of predictions was calculated using Area under the Receiver Operating Curve (AROC).

resultsPatients who took antidepressants for 14 weeks (LR = 2.007) were more likely to have symptom remission. Prior use of 3 antidepressants reduced the odds of remission (LR = 0.771). Patients who received antidepressants below therapeutic dose were 5 times less likely to experience remission (LR = 0.204). Antidepressant that were augment or switched, almost never led to remission (LR = 0.008, LR = 0.002 respectively). Patterns of antidepressant use accurately (AROC = 0.93) predicted symptom remission.

conclusionWithin the first 100 days, antidepressants use patterns could serve as a surrogate measure for patient-reported remission of symptoms.

Indexed as

Antidepressive AgentsPatient Reported Outcome MeasuresHumansAntidepressive AgentsAntidepressant effectivenessMedication augmentationMedication switchPrior medication useSTAR*DSymptom remissionTherapeutic dose

Identifiers

PMID33663440
PMCPMC7931356
OpenAlexW3135015054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.